Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Tax expenses hurt Lupin's profit in FY12, but sales up 22% on growth in core markets
May 10 2012
•
By
Anju Ghangurde
More from Alimentary/Metabolic
More from Therapeutic Category